ReviewInternational urology and nephrology2026
Acute kidney injury prediction and prognostication using machine learning.
Review in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Efficacy of 3D-printed bone graft container in the treatment of tibial plateau fractures and postoperative rehabilitation prediction model.BMC surgery · 2026Article
- Machine Learning-Based Prediction and Feature Attribution Analysis of Contrast-Associated Acute Kidney Injury in Patients with Acute Myocardial Infarction.Medicina (Kaunas, Lithuania) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute Kidney Injury (AKI) is a major health concern with high costs and poor outcomes, partly due to late diagnosis. This paper reviews the application of artificial intelligence (AI) and machine learning (ML) to overcome these limitations by enabling earlier and more accurate prediction and prognostication of AKI. Many studies on AI and ML models used to predict and prognosticate AKI were included in the review. The focus was on models that analyze complex datasets, including real-time data streams like novel biomarkers and continuous vital signs, to achieve earlier and more accurate predictions than conventional methods. ML models show high predictive accuracy for AKI onset and outcomes across various clinical settings, including intensive care units, sepsis, and postoperative and postcontrast situations, with key findings like the successful integration of real-time data to reflect the evolving nature of kidney injury. AI and ML offer a powerful, proactive solution for AKI management. By leveraging diverse data, these technologies can significantly improve patient outcomes and reduce healthcare costs. While their promising performance warrants further exploration, successful clinical integration will require user-friendly platforms and continued validation.
Indexed as
Identifiers
41436719What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.